Bcl‐xL protein: Predictor of complete tumor response in patients with oral cancer treated with curative radiotherapy

Abstract

Our study suggests that Bcl-xL expression along with clinical parameters may be useful for identifying patients with oral cancer likely to draw maximum benefit from curative radiotherapy.